Rivaroxaban et risque de saignement digestif
Rev Med Suisse
.
2022 Jan 26;18(766):134.
doi: 10.53738/REVMED.2022.18.766.134.
[Article in French]
Author
Sonia Aslan
1
Affiliation
1
Unisanté, Lausanne.
PMID:
35084141
DOI:
10.53738/REVMED.2022.18.766.134
No abstract available
Publication types
News
MeSH terms
Dabigatran
Hemorrhage*
Humans
Rivaroxaban*
Substances
Rivaroxaban
Dabigatran